Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Carbonylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111423381A reveals a mild palladium-catalyzed carbonylation route for high-purity 2-trifluoromethyl imidazoles, offering significant cost reduction and scalable manufacturing advantages.
Patent CN111423381A details a novel Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering safer precursors and high yields for API intermediates.
Patent CN115286553B reveals efficient indole synthesis via nickel catalysis. Reduces steps and cost for pharmaceutical intermediates manufacturing supply chain reliability.
Patent CN113045489B details a novel Pd-catalyzed aminocarbonylation route for 3-arylquinolin-2(1H)one derivatives, offering cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN112694430B reveals a safe palladium-catalyzed route using solid CO sources, offering significant cost reduction in API manufacturing and reliable supply chains.
Novel Pd-catalyzed pathway reduces costs and enhances supply chain reliability for high-purity chroman amide pharmaceutical intermediates manufacturing globally.
Novel CuCl catalyzed method offers cost reduction and scalable production for high purity pharmaceutical intermediates without anhydrous conditions.
Patent CN112239456B details a novel Pd-catalyzed carbonylation route for 2,3-dihydroquinolones, offering cost reduction in API manufacturing and scalable production.
Patent CN112239384B reveals a novel nickel-catalyzed carbonylation method using sulfonyl chlorides, offering safer routes for high-purity pharmaceutical intermediate manufacturing.
Novel Pd-catalyzed carbonylation method avoids thiols. High yield, scalable process for reliable pharmaceutical intermediate supply chains.
Novel nickel-catalyzed method for ketone nitriles offers mild conditions and cost efficiency for pharmaceutical intermediate manufacturing supply chains.
Patent CN114907215B reveals mild decarbonylative hydroamination. Enables cost reduction in pharma manufacturing with high-purity amine intermediates and scalable processes.
Patent CN115353511A details a novel Pd-catalyzed multi-component route for carbonyl-bridged biheterocycles, offering safer conditions and cost reduction in API manufacturing.
Novel palladium-catalyzed carbonylation patent CN113735826B enables efficient synthesis. Offers supply chain reliability and cost reduction for pharmaceutical intermediate manufacturing globally.
Novel CuCl-catalyzed route for 1,2,4-triazolyl arylamines offers scalable manufacturing and cost reduction for pharmaceutical intermediate supply chains globally.
Patent CN115260188A details a novel cobalt-catalyzed carbonylation for tetrahydro-beta-carbolinones, offering a cost-effective alternative to palladium methods for API intermediates.
Patent CN112239456B details a safe Pd-catalyzed carbonylation route for 2,3-dihydroquinolones, offering reliable pharmaceutical intermediate supply and simplified manufacturing.
Patent CN114195726B reveals efficient CuCl catalyzed route. Reduces costs and simplifies supply chain for pharmaceutical intermediates significantly.
Patent CN111423381A reveals a mild Pd-catalyzed carbonylation route for high-purity 2-trifluoromethyl imidazoles, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel Pd-catalyzed carbonylation method for indole and benzoxazine compounds. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.